New classification for identifying HR myeloma based on cytogenetic abnormalities
Dr. Christlieb discusses his work developing new PET tracers based on fluorine-18 and radioactive copper isotopes and additional techniques that may make the tracers easier to use in the clinic.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Cancer mutation prediction using artificial intelligence
Best practice in HRRm testing in patients with metastatic prostate cancer
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Community-based breast cancer control programme in the Philipines
Initiatives for cancer control in Indonesia